Cargando…

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study

AIMS: Atrial fibrillation (AF) risk factors translate into disease progression. Whether this affects women and men differently is unclear. We aimed to investigate sex differences in risk factors, outcome, and quality of life (QoL) in permanent AF patients. METHODS AND RESULTS: The Rate Control Effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloosterman, Mariëlle, Crijns, Harry J G M, Mulder, Bart A, Groenveld, Hessel F, Van Veldhuisen, Dirk J, Rienstra, Michiel, Van Gelder, Isabelle C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657385/
https://www.ncbi.nlm.nih.gov/pubmed/31747018
http://dx.doi.org/10.1093/europace/euz300
_version_ 1783608490634248192
author Kloosterman, Mariëlle
Crijns, Harry J G M
Mulder, Bart A
Groenveld, Hessel F
Van Veldhuisen, Dirk J
Rienstra, Michiel
Van Gelder, Isabelle C
author_facet Kloosterman, Mariëlle
Crijns, Harry J G M
Mulder, Bart A
Groenveld, Hessel F
Van Veldhuisen, Dirk J
Rienstra, Michiel
Van Gelder, Isabelle C
author_sort Kloosterman, Mariëlle
collection PubMed
description AIMS: Atrial fibrillation (AF) risk factors translate into disease progression. Whether this affects women and men differently is unclear. We aimed to investigate sex differences in risk factors, outcome, and quality of life (QoL) in permanent AF patients. METHODS AND RESULTS: The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) randomized 614 patients, 211 women and 403 men, to lenient or strict rate control. In this post hoc analysis risk factors, cardiovascular events during 3-year follow-up (cardiovascular death, heart failure hospitalization, stroke, systemic embolism, bleeding, and life-threatening arrhythmic events), outcome parameters, and QoL were compared between the sexes. Women were older (71 ± 7 vs. 66 ± 8 years, P < 0.001), had more hypertension (70 vs. 57%, P = 0.002), and heart failure with preserved ejection fraction (36 vs. 17%, P < 0.001), but less coronary artery disease (13 vs. 21%, P = 0.02). Women had more risk factors (3.7 ± 1.2 vs. 2.9 ± 1.4, P < 0.001) Cardiovascular events occurred in 46 (22%) women and 59 (15%) men (P = 0.03). Women had a 1.52 times [95% confidence interval (CI) 1.03–2.24] higher yearly cardiovascular event-rate [8.2% (6.0–10.9) vs. 5.4% (4.1–6.9), P = 0.03], but this was no longer significant after adjusting for the number of underlying risk factors. Women had reduced QoL, irrespective of age and heart rate but negatively influenced by their risk factors. CONCLUSION: In this permanent AF population, women had more accumulation of AF risk factors than men. The observed higher cardiovascular event rate in women was no longer significant after adjusting for the number of risk factors. Further, QoL was negatively influenced by the higher number of risk factors in women. This suggests that sex differences may be driven by the greater risk factor burden in women.
format Online
Article
Text
id pubmed-7657385
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76573852020-11-17 Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study Kloosterman, Mariëlle Crijns, Harry J G M Mulder, Bart A Groenveld, Hessel F Van Veldhuisen, Dirk J Rienstra, Michiel Van Gelder, Isabelle C Europace Clinical Research AIMS: Atrial fibrillation (AF) risk factors translate into disease progression. Whether this affects women and men differently is unclear. We aimed to investigate sex differences in risk factors, outcome, and quality of life (QoL) in permanent AF patients. METHODS AND RESULTS: The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) randomized 614 patients, 211 women and 403 men, to lenient or strict rate control. In this post hoc analysis risk factors, cardiovascular events during 3-year follow-up (cardiovascular death, heart failure hospitalization, stroke, systemic embolism, bleeding, and life-threatening arrhythmic events), outcome parameters, and QoL were compared between the sexes. Women were older (71 ± 7 vs. 66 ± 8 years, P < 0.001), had more hypertension (70 vs. 57%, P = 0.002), and heart failure with preserved ejection fraction (36 vs. 17%, P < 0.001), but less coronary artery disease (13 vs. 21%, P = 0.02). Women had more risk factors (3.7 ± 1.2 vs. 2.9 ± 1.4, P < 0.001) Cardiovascular events occurred in 46 (22%) women and 59 (15%) men (P = 0.03). Women had a 1.52 times [95% confidence interval (CI) 1.03–2.24] higher yearly cardiovascular event-rate [8.2% (6.0–10.9) vs. 5.4% (4.1–6.9), P = 0.03], but this was no longer significant after adjusting for the number of underlying risk factors. Women had reduced QoL, irrespective of age and heart rate but negatively influenced by their risk factors. CONCLUSION: In this permanent AF population, women had more accumulation of AF risk factors than men. The observed higher cardiovascular event rate in women was no longer significant after adjusting for the number of risk factors. Further, QoL was negatively influenced by the higher number of risk factors in women. This suggests that sex differences may be driven by the greater risk factor burden in women. Oxford University Press 2019-11-20 /pmc/articles/PMC7657385/ /pubmed/31747018 http://dx.doi.org/10.1093/europace/euz300 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research
Kloosterman, Mariëlle
Crijns, Harry J G M
Mulder, Bart A
Groenveld, Hessel F
Van Veldhuisen, Dirk J
Rienstra, Michiel
Van Gelder, Isabelle C
Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
title Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
title_full Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
title_fullStr Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
title_full_unstemmed Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
title_short Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
title_sort sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the race ii study
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657385/
https://www.ncbi.nlm.nih.gov/pubmed/31747018
http://dx.doi.org/10.1093/europace/euz300
work_keys_str_mv AT kloostermanmarielle sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy
AT crijnsharryjgm sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy
AT mulderbarta sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy
AT groenveldhesself sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy
AT vanveldhuisendirkj sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy
AT rienstramichiel sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy
AT vangelderisabellec sexrelateddifferencesinriskfactorsoutcomeandqualityoflifeinpatientswithpermanentatrialfibrillationresultsfromtheraceiistudy